非ST段抬高性心肌梗死危险因素的研究进展  

Research Progress on the Risk Factors of Non-ST Segment Elevation Myocardial Infraction

作　　者：徐慧 龚开政 张振刚 

机构地区：[1]扬州大学第二临床学院心血管内科,江苏扬州225001

出　　处：《医学综述》2014年第16期2961-2963,共3页Medical Recapitulate

摘　　要：非ST段抬高性心肌梗死临床表现多样,冠状动脉病变程度及血流动力学变化不一,预后差异较大。血清学指标已在临床中运用多年,如血浆肌酸激酶、肌钙蛋白、肌红蛋白、转氨酶等作为心肌梗死患者病理改变中的血清学产物,参与心肌梗死的病理进程。目前,对血清学指标在心血管疾病危险度预测方面又有了新的认识,如C反应蛋白、脑钠肽、趋化素、脂肪酸结合蛋白、基质金属蛋白酶9、热激蛋白70。该文主要对心肌梗死的危险因素——血清学指标进行综述。The clinical manifestations of non-ST segment elevation myocardial infraction are various, and the degree of coronary artery lesions and hemodynamic changes are different,which lead to different prognosis results. Serological indicators have been used in clinical practice for many years, such as plasma creatine kinase, troponin, myoglobin, aminotransferase, which participate in the pathological process of myocardial infraction as the serological products of pathological changes in myocardial infraction patients. At present, there has been new serological indicators found that function in the severity prediction of cardiovascular diseases,such as CRP, BNP, Chemerln, FABP, MMP-9, HSPT0. Here is to make a review of the main risk factors--serological indicators in non-ST segment elevation myocardial infraction.

关 键 词：急性非ST段提高性心肌梗死 危险因素 C反应蛋白 脑钠肽 趋化素 脂肪酸结合蛋白 基质金属蛋白酶9 热激蛋白70 

分 类 号：R541[医药卫生—心血管疾病]